- Research works
- 2 ▲ 614% vs 2013–17
- Citations
- 15 6.6 per fractional work
- Top-10% rate
- 0.0% record average 16.5%
- Open access
- 21% world 28%
Not ranked overall: CL Medical (France) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Which research topics does CL Medical (France) publish most on?
By volume in 2022–2025: Chronic Myeloid Leukemia Treatments, Chronic Lymphocytic Leukemia Research and Renal Diseases and Glomerulopathies.
- 1 Chronic Myeloid Leukemia Treatments Hematology 0 works
- 2 Chronic Lymphocytic Leukemia Research Genetics 0 works
- 3 Renal Diseases and Glomerulopathies Nephrology 0 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has CL Medical (France)'s research output changed?
Output in 2018–2022 was 614% higher than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Sainte-Foy-lès-Lyon
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.